Renovascular Hypertension: Clinical Features, Differential Diagnoses and Basic Principles of Treatment

1. Rimoldi SF, Scherrer U, Masserli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 2014; 35(19): 1245-54.Search in Google Scholar

2. Sarafidis PA, Bakris GL. Resistant Hypertension. J Am Col Cardiol 2008; 52(22): 1749-57.10.1016/j.jacc.2008.08.03619022154Search in Google Scholar

3. Fagard RH. Resistant Hypertension. Heart 2012; 98(3): 254-61.10.1136/heartjnl-2011-30074122199020Search in Google Scholar

4. Petrović D. Resistant Hypertension: etiopathogenesis, diagnosis, and treatment. In: Acute kidney injury in clinical practice. Petrović D. Ed. Kragujevac: Interprint 2012: 349-52.Search in Google Scholar

5. Baumgartner I, Lerman LO. Renovascular hypertension: screening and modern management. Eur Heart J 2011; 32(13): 1590-8.10.1093/eurheartj/ehq510312829821273200Search in Google Scholar

6. Petrović D. Renovascular hypertension: etiopathogenesis, diagnosis, and treatment. In: Acute kidney injury in clinical practice. Petrović D. Ed. Kragujevac: Interprint 2012: 353-63.Search in Google Scholar

7. Slovut DP, Onlin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350(18): 1862-71.10.1056/NEJMra03239315115832Search in Google Scholar

8. Sperati CJ, Aggarwal N, Arepally A, Atta MG. Fibromuscular dysplasia. Kidney Int 2009; 75(3): 333-6.10.1038/ki.2008.23218528320Search in Google Scholar

9. Clarkson MR, Magee CN, Brenner BM. Renovascular Hypertension and Ischemic Nephropathy. In: The Kidney. Clarkson MR, Magee CN, Brenner BM. Eds. Philadelphia: Oxford University Press 2010: 468-86.10.1016/B978-1-4160-6640-8.00023-3Search in Google Scholar

10. Adamczak M, Wiecek A. Ischemic nephropathy - pathogenesis and treatment. Nefrologia 2012; 32(4): 432-8.Search in Google Scholar

11. Messerli FH, Bangalore S, Makani H, Rimoldi SF, Allemann Y, White CJ, Textor S, Sleight P. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome. Eur Heart J 2011; 32(18): 2231-7.10.1093/eurheartj/ehr05621406441Search in Google Scholar

12. Petrović D. Vojinović R, Lukić S, Novaković B, Mijailović M, Jagić N. Renovascular hypertension: diagnostic and therapy. Medicus 2005; 6(3): 39-42.Search in Google Scholar

13. Radermacher J, Haller H. The right diagnostic workup: investigating renal and renovascular disorders. J Hypertens 2003; 21 (Suppl 2): 19-24.10.1097/00004872-200305002-0000412929903Search in Google Scholar

14. Petrović D, Novaković B, Jagić N, Poskurica M, Stojimirović B. Doppler ultrasonography in renovascular hypertension. In: Cardionephrology 4. Radenković S. Ed. Niš: GIP PUNTA 2009: 188-93.Search in Google Scholar

15. Granata A, Fiorini F, Andrulli S, Logias F, Galleni M, Romano G, Sicurezza E, Fiore CE. Doppler ultrasound and renal artery stenosis: An overview. J Ultrasound 2009; 12(4): 133-43.10.1016/j.jus.2009.09.006356745623397022Search in Google Scholar

16. Chen W, Kayler LK, Zand MS, Muttana R, Chernyak V, DeBoccardo GO. Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy. Clin Kidney J 2015; 8(1): 71-8.10.1093/ckj/sfu132431043425713713Search in Google Scholar

17. Petrović D. Contrast nephropathy: etiopathogenesis, diagnosis, and treatment. In: Acute kidney injury in clinical practice. Petrović D. Ed. Kragujevac: Interprint 2012: 373-88.Search in Google Scholar

18. Petrović D. Nephrogenic systemic fibrosis: etiopathogenesis, diagnosis, and treatment. In: Acute kidney injury in clinical practice. Petrović D. Ed. Kragujevac: Interprint 2012: 389-95.Search in Google Scholar

19. Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Practice Nephrol 2006; 2(4):198-208.10.1038/ncpneph015116932426Search in Google Scholar

20. Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol 2011; 7(8): 485-95.10.1038/nrendo.2011.7621610687Search in Google Scholar

21. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenze-Roquelpo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metabolism 2007; 3(2): 92-102.10.1038/ncpendmet039617237836Search in Google Scholar

22. Romero CA, Orias M, Weir M. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol 2015; 11: 242-52.10.1038/nrendo.2015.6709762225666495Search in Google Scholar

23. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler Ultrasonography to predict the outcome therapy for renal arterystenosis. N Engl J Med 2001; 344(6): 410-7.10.1056/NEJM20010208344060311172177Search in Google Scholar

24. Radermacher J. Echo-Doppler to predict the outcome for renal artery stenosis. J Nephrol 2002; 15(Suppl 6): 69-76.Search in Google Scholar

25. Wiecek A, Chudek J, Adamczak M. Indications for renal revascularisation - the landscape after the ASTRAL study. Nephrol Dial Transplant 2010; 25(8): 2399-402.10.1093/ndt/gfq12020501462Search in Google Scholar

26. Plouin PF, Bax L. Diagnosis and treatment of renal artery stenosis. Nat Rev Nephrol 2010; 6(3): 151-9.10.1038/nrneph.2009.23020101256Search in Google Scholar